EUVIMEDEUVIMED entdecken
Vergleichsstudie

Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA

Victor L Van de Wiele, Aaron S Kesselheim, Deborah Gleeson, Zhigang Lu, Sean S Tu, Benjamin N Rome

Pharmaceutical Medicine · 2024

DOI: 10.1007/s40290-024-00527-w ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmaceutical Medicine, 2024. Verfasst von Victor L Van de Wiele und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Law, University of Cambridge, The Sir David Williams Building, 10 West Road, Cambridge, CB3 9DZ, UK. vv306@cam.ac.uk. Hauptthemen laut MEDLINE: Drugs, Generic, Prescription Drugs, Drug Industry. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Arnold Ventures, Commonwealth Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, GenericPrescription DrugsDrug IndustryUnited StatesFranceAustraliaHumansEconomic CompetitionDrug ApprovalTime FactorsMarketing

Substanzen

Drugs, GenericPrescription Drugs

Autor:innen und Institutionen

  • Faculty of Law, University of Cambridge, The Sir David Williams Building, 10 West Road, Cambridge, CB3 9DZ, UK. vv306@cam.ac.uk.
  • Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. vv306@cam.ac.uk.
  • Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • School of Psychology and Public Health, La Trobe University, Melbourne, VIC, 3086, Australia.
  • West Virginia University College of Law, Morgantown, WV, USA.

Förderung

  • Arnold Ventures
  • Commonwealth Fund

Zitieren

APA

Van de Wiele, V. L., Kesselheim, A. S., Gleeson, D., Lu, Z., Tu, S. S., & Rome, B. N. (2024). Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-024-00527-w

Vancouver

Van de Wiele VL, Kesselheim AS, Gleeson D, Lu Z, Tu SS, Rome BN. Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA. Pharmaceutical Medicine. 2024. doi:10.1007/s40290-024-00527-w

BibTeX
@article{VandeWiele2024,
  author = {Van de Wiele, Victor L and Kesselheim, Aaron S and Gleeson, Deborah and Lu, Zhigang and Tu, Sean S and Rome, Benjamin N},
  title = {Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA},
  journal = {Pharmaceutical Medicine},
  year = {2024},
  doi = {10.1007/s40290-024-00527-w}
}
Kostenlos starten →